What is Anxiety Due to Another Medical Condition?
Anxiety disorder due to another medical condition is a distinct DSM-5 diagnosis (ICD-10 code F06.4) characterized by clinically significant anxiety symptoms that are the direct physiological consequence of an underlying physical illness, rather than a psychological reaction to being sick. 1
Core Diagnostic Features
This diagnosis requires establishing that anxiety symptoms are occurring in the context of a physical illness and represent a direct pathophysiological effect of that medical condition 1. The anxiety must cause clinically significant distress or functional impairment in social, occupational, or other important life domains.
Critical Distinction from Other Anxiety Presentations
The key differentiating factor is causation mechanism:
- Anxiety due to medical condition: Direct physiological effect (e.g., hyperthyroidism causing anxiety through excess thyroid hormone)
- Adjustment disorder with anxiety: Psychological reaction to the stress of having a medical illness
- Primary anxiety disorder: Anxiety occurring independently, though may coexist with medical conditions
Common Medical Conditions Associated with Anxiety
Medical disorders frequently causing anxiety as a direct physiological consequence include 2, 3:
Endocrine disorders:
- Hyperthyroidism (most common)
- Diabetes
- Cushing's syndrome
- Pheochromocytoma
Cardiovascular conditions:
- Coronary heart disease
- Mitral valve prolapse
- Arrhythmias
Respiratory disorders:
- Asthma
- Chronic obstructive pulmonary disease (COPD)
Neurological conditions:
- Seizure disorders
- Parkinson's disease (particularly social anxiety)
- Striatal disorders (particularly OCD-like symptoms)
- Head injury (particularly PTSD symptoms)
Other conditions:
- Chronic pain syndromes
- Migraine
- Irritable bowel syndrome
- Peptic ulcer disease
- Rheumatoid arthritis
Clinical Assessment Approach
Look for these specific indicators that anxiety is medically-caused:
- Temporal relationship: Anxiety onset coincides with medical condition onset or exacerbation
- Symptom pattern: Anxiety severity fluctuates with medical condition severity
- Laboratory/physical findings: Objective evidence of medical pathology (e.g., elevated thyroid hormones, abnormal cardiac testing)
- Treatment response: Anxiety improves when underlying medical condition is treated
- Absence of pre-existing anxiety: No history of primary anxiety disorder before medical illness
Important Clinical Pitfalls
Bidirectional relationships complicate diagnosis 4. Medical conditions and anxiety can influence each other through complex "somato-psycho-somatic" pathways. For example:
- Anxiety can worsen pain perception in chronic pain conditions 2
- Cardiovascular disease can cause anxiety, but anxiety also increases cardiovascular risk
- Patients with both GAD and pain conditions experience and register pain differently than those with pain alone 2
Under-recognition is common 5. Anxiety disorders in medical patients are frequently missed because clinicians attribute all symptoms to the medical condition or assume anxiety is merely a "normal" reaction to illness.
Treatment Implications
Treat the underlying medical condition first 5. When anxiety is truly due to another medical condition, addressing the primary pathology should reduce anxiety symptoms. However, concurrent symptomatic treatment of anxiety may be necessary while medical treatment takes effect.
Treatment selection must account for medical comorbidities 2:
- Certain psychotropic medications may be contraindicated or require dose adjustment
- Drug-drug interactions with medications for the medical condition must be considered
- Some anxiety treatments (e.g., certain SSRIs) may benefit both anxiety and the medical condition
Long-term perspective matters 2. In younger patients, treating anxiety may decrease vulnerability to developing medical conditions later, given the bidirectional relationship between anxiety and physical illness.
The diagnosis carries prognostic significance: comorbid anxiety and medical illness leads to worse outcomes for both conditions, increased healthcare utilization, and reduced quality of life across bio-psycho-social domains 4, 5.